November 08, 2018
Avella of Deer Valley Inc. is recalling hydromorphone (0.2 mg/mL) in NS 100-mL bags over sterility concerns, according to the November 7, 2018, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects 360 bags from lot 8/27/18 0215 22110P (Exp. 12/10/18), which were distributed throughout the United States.
Avella of Deer Valley Inc. voluntarily initiated the recall October 19, 2018. On November 1, 2018, the FDA designated the recall Class II. A Class II designation communicates that use of the recalled product could cause temporary or medically reversible adverse health consequences. A remote possibility of serious harm also exists.
Intravenous hydromorphone is a narcotic pain reliever used to treat moderate to severe pain.
For more Pharmacy Learning Network articles, visit the homepage
To learn about Pharmacy Learning Network Live meetings, click here